JPH0948868A - Antibacterial porous film and method for producing the same - Google Patents

Antibacterial porous film and method for producing the same

Info

Publication number
JPH0948868A
JPH0948868A JP20103195A JP20103195A JPH0948868A JP H0948868 A JPH0948868 A JP H0948868A JP 20103195 A JP20103195 A JP 20103195A JP 20103195 A JP20103195 A JP 20103195A JP H0948868 A JPH0948868 A JP H0948868A
Authority
JP
Japan
Prior art keywords
film
antibacterial
porous film
sheet
stretching
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20103195A
Other languages
Japanese (ja)
Inventor
Masao Kameyama
山 正 雄 亀
Akito Nishimura
村 明 人 西
Kozo Morishige
重 浩 三 森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Petrochemical Industries Ltd
Original Assignee
Mitsui Petrochemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Petrochemical Industries Ltd filed Critical Mitsui Petrochemical Industries Ltd
Priority to JP20103195A priority Critical patent/JPH0948868A/en
Publication of JPH0948868A publication Critical patent/JPH0948868A/en
Pending legal-status Critical Current

Links

Landscapes

  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an antimicrobial porous film which has enlarged areas contacting the antimicrobial agent to air and can reveal excellent antimicrobial properties with reduced doses by drawing a film or a sheet made of a composition of a polyolefin resin, an antimicrobial agent and a filler. SOLUTION: A resin composition containing (A) a polyolefin resin such as polyethylene, polypropylene and the like, preferably in an amount of 100 pts.wt., (B) an antimicrobial agent, preferably in an amount of 0.2-5 pts.wt., (C) a filter, preferably calcium carbonate or barium sulfate, preferably in an amount of 5-200 pts.wt., is processed to a film or sheet, then the film or sheet is drawn. The resultant film has a porosity of >=50%, particularly 60-90%, an air permeability of preferably <=1,000sec/100cc and the hydraulic pressure resistance, preferably >=1,000mmHg. This film is obtained by melt forming a composition containing the component A and the component B into a film or sheet and drawing the sheet or film mono- or biaxially.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は抗菌性多孔フィルム
およびその製造方法に関し、特に、多孔性を有し、少量
の抗菌剤の配合により抗菌性を発揮する抗菌性多孔フィ
ルムおよびその製造方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibacterial porous film and a method for producing the same, and more particularly to an antibacterial porous film having porosity and exhibiting antibacterial properties by blending a small amount of an antibacterial agent, and a method for producing the same.

【0002】[0002]

【従来の技術】近年、抗菌性フィルムが、MRSA(院
内感染)対策用フィルム、前掛け、衣料用シーツ、保護
衣等の用途に利用されている。
2. Description of the Related Art In recent years, antibacterial films have been used for applications such as MRSA (nosocomial infection) countermeasure films, aprons, clothes sheets and protective clothes.

【0003】この抗菌性フィルムは、一般に、抗菌剤を
フィルム中に分散、配合してなるものである。
This antibacterial film is generally prepared by dispersing and compounding an antibacterial agent in the film.

【0004】[0004]

【発明が解決しようとする課題】しかし、前記従来の抗
菌性フィルムは、多量の抗菌剤を配合しなければ、十分
な抗菌性を発揮することができないという欠点があっ
た。
However, the above-mentioned conventional antibacterial film has a drawback that it cannot exhibit sufficient antibacterial properties unless a large amount of antibacterial agent is added.

【0005】そこで、本発明の目的は、従来の抗菌性フ
ィルムの問題点を改良し、多孔化することにより、抗菌
剤と空気との接触面積を大きくし、少量の抗菌剤の配合
により十分な抗菌性を発揮することができる抗菌性多孔
フィルムを提供することにある。
Therefore, the object of the present invention is to improve the problems of the conventional antibacterial film and to make it porous so that the contact area between the antibacterial agent and the air is increased, and the addition of a small amount of the antibacterial agent is sufficient. An object is to provide an antibacterial porous film capable of exhibiting antibacterial properties.

【0006】[0006]

【課題を解決するための手段】前記課題を解決するため
に、本発明は、ポリオレフィン樹脂と、抗菌剤と、充填
剤を含む樹脂組成物のフィルムまたはシートを延伸して
なる抗菌性多孔フィルムを提供するものである。
In order to solve the above-mentioned problems, the present invention provides an antibacterial porous film obtained by stretching a film or sheet of a resin composition containing a polyolefin resin, an antibacterial agent and a filler. It is provided.

【0007】また、本発明は、前記抗菌性多孔フィルム
の製造方法として、ポリオレフィン樹脂と、抗菌剤と、
充填剤とを含む樹脂組成物を、フィルムまたはシートに
溶融成形した後、延伸する工程を有する抗菌性多孔フィ
ルムの製造方法をも提供するものである。
The present invention also provides, as a method for producing the antibacterial porous film, a polyolefin resin, an antibacterial agent,
The present invention also provides a method for producing an antibacterial porous film, which comprises a step of melt-molding a resin composition containing a filler into a film or sheet, and then stretching.

【0008】以下、本発明の抗菌性多孔フィルムおよび
その製造方法について詳細に説明する。
The antibacterial porous film of the present invention and the method for producing the same will be described below in detail.

【0009】本発明の抗菌性多孔フィルムは、ポリオレ
フィン樹脂と、抗菌剤と、充填剤とを必須成分とする樹
脂組成物からなるものである。この樹脂組成物の必須成
分であるポリオレフィン樹脂は、α−オレフィンの単独
重合体、2種以上のα−オレフィンからなる共重合体、
α−オレフィンと該α−オレフィンと共重合可能な単量
体との共重合体、またはこれらの単独重合体と共重合体
との混合物等が挙げられる。α−オレフィンとしては、
例えば、エチレン、プロピレン、ブテン、4−メチル−
1−ペンテン等が挙げられる。また、α−オレフィンと
共重合可能な単量体としては、例えば、酢酸ビニル、ア
クリル酸、メタクリル酸等が挙げられる。このポリオレ
フィン樹脂は、α−オレフィンの含有量が、70モル%
以上のものである。これらのポリオレフィン樹脂の具体
例として、ポリエチレン、ポリプロピレン、ポリブテ
ン、ポリ4−メチル−1−ペンテン、およびこれらを主
成分とするランダムあるいはブロック共重合体、エチレ
ン−酢酸ビニル共重合体、エチレン−アクリル酸共重合
体、エチレン−メタクリル酸共重合体等が挙げられる。
The antibacterial porous film of the present invention comprises a resin composition containing a polyolefin resin, an antibacterial agent and a filler as essential components. The polyolefin resin, which is an essential component of this resin composition, is a homopolymer of α-olefin, a copolymer composed of two or more α-olefins,
Examples thereof include a copolymer of α-olefin and a monomer copolymerizable with the α-olefin, or a mixture of these homopolymers and copolymers. As an α-olefin,
For example, ethylene, propylene, butene, 4-methyl-
1-pentene and the like. Examples of the monomer copolymerizable with the α-olefin include vinyl acetate, acrylic acid, methacrylic acid and the like. This polyolefin resin has an α-olefin content of 70 mol%.
That's all. Specific examples of these polyolefin resins include polyethylene, polypropylene, polybutene, poly-4-methyl-1-pentene, and random or block copolymers containing these as main components, ethylene-vinyl acetate copolymers, ethylene-acrylic acid. Examples thereof include copolymers and ethylene-methacrylic acid copolymers.

【0010】本発明において、このポリオレフィン樹脂
は、抗菌性多孔フィルムの製造工程における成形性と、
高強度、引裂強度等の成形物性が良好となる点で、好ま
しくはMFRが0.01〜15g/10分、特に好まし
くは0.1〜8g/10分であるものである。
In the present invention, the polyolefin resin has moldability in the manufacturing process of the antibacterial porous film,
From the viewpoint of good molding properties such as high strength and tear strength, the MFR is preferably 0.01 to 15 g / 10 minutes, particularly preferably 0.1 to 8 g / 10 minutes.

【0011】本発明において、樹脂組成物の必須成分で
ある抗菌剤としては、所要の抗菌特性を有するものであ
れば、無機系抗菌剤、有機系抗菌剤のいずれも使用する
ことができ、用途、抗菌力、安全性、耐熱性、耐候性、
耐水性、耐薬品性、外観等の必要な特性に応じて適宜選
択される。
In the present invention, as the antibacterial agent which is an essential component of the resin composition, both inorganic antibacterial agents and organic antibacterial agents can be used as long as they have the required antibacterial properties. , Antibacterial activity, safety, heat resistance, weather resistance,
It is appropriately selected depending on the required properties such as water resistance, chemical resistance, and appearance.

【0012】無機系抗菌剤としては、例えば、ゼオライ
ト、リン酸ジルコニウム、ハイドロキシアパタイト、リ
ン酸塩ガラス、リン酸塩系セラミックス等の無機系担体
の骨格構造内に、銀、銅、亜鉛等の抗菌性イオンを導入
した形態のものが挙げられる。この無機系抗菌剤の具体
例として、(株)シナネンゼオミック製のゼオミック、
(株)鐘紡製のバクテキラー、東亜合成(株)製のノバ
ロン、サンギ社製のアバサイダー、石塚硝子社製のイオ
ンビュアー、松下電産社製のアメントップ、触媒化成社
製のアイス、太平化学産業社製のシルバーエース、ラサ
工業社製のラサップ等が挙げられる。
Examples of the inorganic antibacterial agents include antibacterial agents such as silver, copper and zinc in the skeleton structure of an inorganic carrier such as zeolite, zirconium phosphate, hydroxyapatite, phosphate glass and phosphate ceramics. An example is a form in which a sex ion is introduced. As a specific example of this inorganic antibacterial agent, Zeomic manufactured by Sinanen Zeomic Co., Ltd.
Bactekiller manufactured by Kanebo Co., Ltd., Novalon manufactured by Toagosei Co., Ltd., Ava Cider manufactured by Sangi Co., Ltd., Ion Viewer manufactured by Ishizuka Glass Co., Ltd., Amen Top manufactured by Matsushita Electric Industrial Co., Ltd. Examples thereof include Silver Ace manufactured by Rasa Kogyo Co., Ltd. and Lassap manufactured by Rasa Kogyo.

【0013】有機系抗菌剤としては、例えば、2−オク
チル−4−イソチアゾリン−3−オン、10,10’−
オキシビスフェノキシアルシン、2−(4−チアゾリ
ル)−ベンズイミダゾール、N−(フルオロジクロロメ
チルチオ)−フタルイミド、2−メチルカーボニルアミ
ノベンズイミダゾール、2,3,5,6−テトラクロロ
−4−(メチルチオ)−フタルイミド、トリメトキシシ
リル−プロピリオクタデシルアンモニウムクロライド、
2−N−オクチル−4−イソチアゾリン−3−オン、ビ
ス(2−ピリジルチオ−1−オキシド)亜鉛等が挙げら
れる。これらの有機抗菌剤の具体例として、大和化学工
業(株)製のアモルデンSK−950、SK−30W、
モートン・チオコール社製のバイナジン、メルク社製の
テアベンダゾール、バイエル社製のブレベントールA−
3、リーデル・デ・ハーン社製のメルガルBCM、アイ
シーアール社製のデンシルS3、ダウコーニング社製の
バイオシル、ロームアンドハース社製のスケーンM8、
日本オーリン社製のZPT等が挙げられる。
Examples of organic antibacterial agents include 2-octyl-4-isothiazolin-3-one, 10,10'-
Oxybisphenoxyarsine, 2- (4-thiazolyl) -benzimidazole, N- (fluorodichloromethylthio) -phthalimide, 2-methylcarbonylaminobenzimidazole, 2,3,5,6-tetrachloro-4- (methylthio) -Phthalimide, trimethoxysilyl-propyrioctadecyl ammonium chloride,
2-N-octyl-4-isothiazolin-3-one, bis (2-pyridylthio-1-oxide) zinc and the like can be mentioned. Specific examples of these organic antibacterial agents include Amorden SK-950 and SK-30W manufactured by Daiwa Chemical Industry Co., Ltd.
Morton Thiokol's Vinadine, Merck's Theabendazole, Bayer's Breventol A-
3, Melgar BCM made by Riedel de Haan, Dencil S3 made by ICR, Biosil made by Dow Corning, Skene M8 made by Rohm and Haas,
Examples include ZPT manufactured by Olin Japan.

【0014】これらの抗菌剤の中でも、無機質担体に
銀、銅、亜鉛等の抗菌性イオンを導入した形態のもの
が、抗菌性の持続性、耐熱安定性、安全性に優れる点
で、好ましく、特に、抗菌性イオンとして銀イオンを含
むものが、抗菌性が優れているため、好ましい。
Among these antibacterial agents, those in which antibacterial ions such as silver, copper and zinc are introduced into an inorganic carrier are preferable because of excellent antibacterial durability, heat stability and safety. In particular, those containing silver ions as antibacterial ions are preferable because they have excellent antibacterial properties.

【0015】本発明で用いられる樹脂組成物中の抗菌剤
の含有量は、ポリオレフィン樹脂100重量部に対し
て、0.2〜5重量部の割合、好ましくは0.5〜2重
量部の割合である。
The content of the antibacterial agent in the resin composition used in the present invention is 0.2 to 5 parts by weight, preferably 0.5 to 2 parts by weight, based on 100 parts by weight of the polyolefin resin. Is.

【0016】本発明において、樹脂組成物の成分として
用いられる充填剤は、特に制限されず、無機系充填剤ま
たは有機系充填剤のいずれでもよく、両者の組合せでも
よい。この充填剤の具体例として、無機系充填剤として
は、例えば、アルカリ土類金属、周期律表第III 族元素
の酸化物、水酸化物、炭酸塩、硫酸塩、ケイ酸塩等が挙
げられ、有機系充填剤としては、例えば、木粉、パルプ
等のセルロース粉末、シリコーン、フェノール等の架橋
物粉末などが挙げられる。これらは1種単独でも2種以
上を組み合わせても用いられる。これらの中でも、コス
ト、品質の安定性を考慮して、炭酸カルシウム、硫酸バ
リウム等が好ましい。
In the present invention, the filler used as a component of the resin composition is not particularly limited, and may be either an inorganic filler or an organic filler, or a combination of both. Specific examples of this filler include inorganic earth fillers such as alkaline earth metals, oxides, hydroxides, carbonates, sulfates and silicates of Group III elements of the periodic table. Examples of the organic filler include cellulose powder such as wood powder and pulp, and crosslinked powder such as silicone and phenol. These may be used alone or in combination of two or more. Among these, calcium carbonate, barium sulfate and the like are preferable in consideration of cost and stability of quality.

【0017】この充填剤の粒径は、通常、0.1〜8μ
m程度であり、少ない配合量で空孔率を高め、好ましく
は0.5〜5μm程度である。
The particle size of this filler is usually 0.1 to 8 μm.
It is about m, and the porosity is increased with a small blending amount, and preferably about 0.5 to 5 μm.

【0018】また、樹脂組成物には、必要に応じて、ワ
ックス、耐熱安定剤、耐候安定剤、滑剤、帯電防止剤等
の常用の配合剤を、本発明の目的を損なわない範囲で配
合してもよい。
If necessary, a conventional compounding agent such as wax, heat stabilizer, weathering stabilizer, lubricant, antistatic agent, etc. may be added to the resin composition as long as the object of the present invention is not impaired. May be.

【0019】樹脂組成物中におけるポリオレフィン樹
脂、抗菌剤および充填剤の配合割合は、好ましくはポリ
オレフィン樹脂100重量部に対して、抗菌剤0.2〜
5重量部、充填剤20〜100重量部の割合であり、さ
らに好ましくはポリオレフィン樹脂100重量部に対し
て、抗菌剤0.5〜2重量部、充填剤5〜200重量部
の割合である。また、充填剤の配合割合が上記範囲に比
べて少なすぎると、延伸処理によって抗菌性多孔フィル
ムを得ることが困難となり、多すぎると、樹脂組成物を
フィルムまたはシートに溶融成形する際の混練性、分散
性、フィルムまたはシートの成形性が劣り、さらに、フ
ィルムまたはシートの延伸処理による抗菌性多孔フィル
ムの成形における延伸性が劣る。
The mixing ratio of the polyolefin resin, the antibacterial agent and the filler in the resin composition is preferably 0.2 to 100 parts by weight of the polyolefin resin.
5 parts by weight and 20 to 100 parts by weight of the filler, and more preferably 0.5 to 2 parts by weight of the antibacterial agent and 5 to 200 parts by weight of the filler with respect to 100 parts by weight of the polyolefin resin. Further, if the blending ratio of the filler is too small compared to the above range, it becomes difficult to obtain an antibacterial porous film by stretching treatment, and if the blending ratio is too large, the kneadability at the time of melt-molding the resin composition into a film or sheet. , Dispersibility, film or sheet moldability is poor, and further, stretchability in molding of the antibacterial porous film by stretching treatment of the film or sheet is poor.

【0020】また、樹脂組成物の調製は、前記ポリオレ
フィン樹脂、抗菌剤および充填剤、ならびに必要に応じ
て配合される各種の配合剤を、ヘンシェルミキサー、タ
ンブラー型混合機、V型混合機等の常用の混合機を用い
て混合する方法にしたがって行うことができる。
Further, the resin composition is prepared by using the above-mentioned polyolefin resin, antibacterial agent and filler, and various kinds of compounding agents which are compounded as necessary, in a Henschel mixer, a tumbler type mixer, a V type mixer or the like. It can be performed according to the method of mixing using a conventional mixer.

【0021】本発明において、樹脂組成物は、フィルム
またはシートに溶融成形される。この溶融成形は、樹脂
組成物を溶融混練してフィルムまたはシートに成形でき
る方法であればよく、いずれの方法にしたがって行って
もよい。例えば、樹脂組成物を、一軸もしくは二軸のス
クリュー押出機、二軸混練等の常用の装置を用いて溶融
混練した後、インフレーション成形、Tダイによる押出
成形等によってフィルムまたはシートに成形することが
できる。このとき、抗菌剤を表面層に配合する多層成形
法で抗菌性多孔フィルムを製造すれば、少ない量の抗菌
剤で、効率よく抗菌性を発現することができるため、有
効である。
In the present invention, the resin composition is melt-molded into a film or sheet. This melt molding may be performed by any method as long as it can be melt-kneaded to form a film or sheet by melting and kneading the resin composition. For example, a resin composition may be melt-kneaded using a conventional device such as a single-screw or twin-screw extruder or a twin-screw kneader, and then formed into a film or sheet by inflation molding, T-die extrusion molding, or the like. it can. At this time, if the antibacterial porous film is manufactured by a multi-layer molding method in which the antibacterial agent is mixed in the surface layer, the antibacterial property can be efficiently expressed with a small amount of the antibacterial agent, which is effective.

【0022】樹脂組成物の溶融混練時の温度は、通常、
200〜280℃の範囲に調整される。
The temperature during melt kneading of the resin composition is usually
It is adjusted in the range of 200 to 280 ° C.

【0023】また、インフレーション成形では、円形ダ
イから円筒状に一軸延伸または二軸延伸されたフィルム
を引出し、さらにロール延伸により一軸延伸を行うこと
ができる。また、Tダイによる成形では、未配向のシー
トまたはフィルムを成形後、ロール延伸により一軸延
伸、あるいはテンター方式による二軸延伸を行うことが
できる。
Further, in inflation molding, a uniaxially stretched or biaxially stretched film in a cylindrical shape can be drawn out from a circular die and uniaxially stretched by roll stretching. Further, in the molding using a T-die, after forming an unoriented sheet or film, uniaxial stretching by roll stretching or biaxial stretching by a tenter method can be performed.

【0024】本発明において、樹脂組成物の溶融成形に
よって得られるフィルムまたはシートの厚さは、特に制
限されず、用途に応じて適宜選択される。
In the present invention, the thickness of the film or sheet obtained by melt-molding the resin composition is not particularly limited and is appropriately selected according to the application.

【0025】次に、フィルム状またはシート状に成形さ
れた樹脂組成物は、延伸処理され、抗菌性多孔フィルム
を得ることができる。この延伸処理は、一軸延伸でも、
二軸延伸でもよく、用途に応じて、適宜選択される。例
えば、一軸延伸の場合には、簡易に延伸処理を行うこと
ができる利点があり、強度の異方性を問題としない用途
には、一軸延伸が有利である。また、二軸延伸の場合に
は、さらに薄膜化が可能であり、剛性の低下による肌ざ
わり性の向上、強度の異方性の解消の目的に有効であ
る。
Next, the resin composition molded into a film or sheet is stretched to obtain an antibacterial porous film. This stretching process, even uniaxial stretching,
It may be biaxially stretched, and is appropriately selected depending on the application. For example, in the case of uniaxial stretching, there is an advantage that the stretching treatment can be easily performed, and uniaxial stretching is advantageous for applications where the anisotropy of strength does not matter. Further, in the case of biaxial stretching, it is possible to further reduce the film thickness, which is effective for the purpose of improving the softness due to the reduction in rigidity and eliminating the anisotropy in strength.

【0026】一軸延伸の場合は、通常、ロール延伸が用
いられ、一段または二段以上の多段で行ってもよい。こ
の時、延伸温度は室温〜樹脂の融点の範囲に調整され、
延伸倍率1.2〜8倍、好ましくは2〜6倍に延伸する
ことによって、空孔率50%以上で、剛性が低く、肌ざ
わりのよい抗菌性多孔フィルムを得ることができる。
In the case of uniaxial stretching, roll stretching is usually used and it may be carried out in one stage or in multiple stages of two or more stages. At this time, the stretching temperature is adjusted in the range of room temperature to the melting point of the resin,
By stretching at a stretch ratio of 1.2 to 8 times, preferably 2 to 6 times, an antibacterial porous film having a porosity of 50% or more, low rigidity and good texture can be obtained.

【0027】二軸延伸の場合は、同時もしくは逐次延伸
が行われる。この時、延伸温度は室温から樹脂の融点ま
でで、延伸倍率は1.2〜8倍、好ましくは2〜6倍で
空孔率50%以上で、剛性が低く、肌ざわりのよい抗菌
性多孔フィルムを得ることができる。
In the case of biaxial stretching, simultaneous or sequential stretching is carried out. At this time, the stretching temperature is from room temperature to the melting point of the resin, the stretching ratio is 1.2 to 8 times, preferably 2 to 6 times, the porosity is 50% or more, the rigidity is low, and the antibacterial porous film has a good texture. Can be obtained.

【0028】また、一軸または二軸延伸処理後、熱処理
を行うと、寸法安定性に優れる抗菌性多孔フィルムを得
ることができるため、有効である。熱処理は、80℃か
らフィルムの融点までの範囲の温度で行うことができ、
通常、高温で短時間に行われる。
Further, it is effective to perform heat treatment after the uniaxial or biaxial stretching treatment, because an antibacterial porous film having excellent dimensional stability can be obtained. The heat treatment can be performed at a temperature ranging from 80 ° C. to the melting point of the film,
Usually, it is performed at high temperature for a short time.

【0029】本発明の抗菌性多孔フィルムの中でも、空
孔率が50%以上のものが、抗菌性が良好で、かつ風合
いに優れる点で、好ましく、さらに空孔率が60〜90
%であるものが好ましい。
Among the antibacterial porous films of the present invention, those having a porosity of 50% or more are preferable in that the antibacterial properties are good and the texture is excellent, and the porosity is 60 to 90.
% Is preferred.

【0030】また、本発明の抗菌性多孔フィルムは、各
種不織布、ワリフ、織布等と複合化して、その強度を向
上させることもできる。
The antibacterial porous film of the present invention can be combined with various non-woven fabrics, wariffs, woven fabrics, etc. to improve its strength.

【0031】[0031]

【実施例】以下、本発明の実施例および比較例によっ
て、本発明を具体的に説明する。
EXAMPLES The present invention will be specifically described below with reference to Examples and Comparative Examples of the present invention.

【0032】(実施例1)LLDPE(三井石油化学工
業社製、ウルトゼックス2021L、MFR:2.1g
/10分、密度:0.920g/cm3 )50重量部
と、炭酸カルシウム(竹原化学社製、WS#1500、
平均粒径:2.5μm)50重量部と、粉末状抗菌剤
((株)シナネンゼオミック製、ゼオミック)1重量部
とを、タンブラーで撹拌混合した。得られた混合物を、
二軸押出機(日本製鋼社製、TEX−44、スクリュー
径:44mm)に供給してシリンダー温度:120/1
40/190℃で溶融混練した後、ダイス温度:220
℃のTダイから押出し、引取速度:6m/minで引き
取って、厚さ500μmのフィルムを得た。得られたフ
ィルムを、延伸温度:75℃、延伸速度:2m/mi
n、および延伸倍率:縦/横=3/1.5倍で同時二軸
延伸して、厚さ120μmの抗菌性多孔フィルムを得
た。得られた抗菌性多孔フィルムについて、抗菌性、延
伸性、空孔率、透気度、透湿度および耐水圧性を、下記
の方法にしたがって評価または測定した。結果を表1に
示す。
Example 1 LLDPE (Ultzex 2021L, manufactured by Mitsui Petrochemical Co., Ltd., MFR: 2.1 g)
/ 10 minutes, density: 0.920 g / cm 3 ) 50 parts by weight, calcium carbonate (manufactured by Takehara Chemical Co., Ltd., WS # 1500,
50 parts by weight (average particle diameter: 2.5 μm) and 1 part by weight of a powdered antibacterial agent (Zeomic, manufactured by Sinanene Zeomic Co., Ltd.) were mixed by stirring with a tumbler. The resulting mixture is
Cylinder temperature: 120/1 by supplying to a twin-screw extruder (TEX-44, screw diameter: 44 mm, manufactured by Nippon Steel Co., Ltd.)
After melt-kneading at 40/190 ° C, die temperature: 220
The film was extruded from a T-die at a temperature of ℃ and drawn at a take-up speed of 6 m / min to obtain a film having a thickness of 500 μm. The obtained film was stretched at a temperature of 75 ° C. and a stretching speed of 2 m / mi.
n, and draw ratio: longitudinal / horizontal = 3 / 1.5 times simultaneous biaxial drawing to obtain an antibacterial porous film having a thickness of 120 μm. With respect to the obtained antibacterial porous film, antibacterial property, stretchability, porosity, air permeability, moisture permeability and water pressure resistance were evaluated or measured according to the following methods. The results are shown in Table 1.

【0033】抗菌性 試験片(約50×50mm)に、黄色ブドウ状球菌の菌
液0.5mlを滴下し、37℃て24時間培養した。そ
の後、滅菌済みリン酸緩衝液にて試験片から菌を洗い出
した。洗い出した液中の生残菌数を、菌数測定用培地を
用いて混釈平板法によって測定した。また、対照として
菌液のみの試験も行った。
Antibacterial property 0.5 ml of a Staphylococcus aureus bacterium solution was dropped on a test piece (about 50 × 50 mm) and cultured at 37 ° C. for 24 hours. Then, the bacteria were washed out from the test piece with a sterilized phosphate buffer solution. The number of surviving bacteria in the washed-out liquid was measured by the pour plate method using a culture medium for measuring the number of bacteria. As a control, a test using only the bacterial solution was also performed.

【0034】延伸性:延伸状態を目視により調査し、下
記の基準で評価した。 ○ 延伸ムラなし、切断なし × 延伸ムラまたは切断あり
Stretchability: The stretched state was visually inspected and evaluated according to the following criteria. ○ No stretching unevenness, no cutting × There is stretching unevenness or cutting

【0035】空孔率:次式より空孔率を求めた。 空孔率=(d0 −d)/d0 ×100 d0 :樹脂組成物の密度 d :延伸フィルムの密度Porosity: The porosity was calculated from the following formula. Porosity = (d 0 −d) / d 0 × 100 d 0 : Density of resin composition d: Density of stretched film

【0036】透気度:JIS P8117に準拠して評
価した。 透湿度:JIS P0208に準拠して評価した。 耐水圧性:JIS L1092に準拠して評価した。
Air permeability: Evaluated according to JIS P8117. Water vapor transmission rate: Evaluated according to JIS P0208. Water pressure resistance: evaluated according to JIS L1092.

【0037】(実施例2)粉末状抗菌剤((株)シナネ
ンゼオミック製、ゼオミック)の使用量を2重量部とし
た以外は、実施例1と同様にして抗菌性多孔フィルムを
製造し、抗菌性、延伸性、空孔率、透気度、透湿度およ
び耐水圧性を評価または測定した。結果を表1に示す。
(Example 2) An antibacterial porous film was produced in the same manner as in Example 1 except that the amount of the powdered antibacterial agent (Zenomic, manufactured by Sinane Zeomic Co., Ltd.) was changed to 2 parts by weight, and an antibacterial film was prepared. Property, stretchability, porosity, air permeability, moisture permeability and water pressure resistance were evaluated or measured. The results are shown in Table 1.

【0038】(実施例3)LLDPEの代わりにポリプ
ロピレン(三井石油化学工業(株)製、ハイポールF−
600、MFR:6g/10分、密度:0.91g/c
3 )を用い、シリンダー温度を160/200/23
0℃、ダイス温度を230℃とし、また、フィルムの延
伸温度を110℃とした以外は、実施例1と同様にして
抗菌性多孔フィルムを製造し、抗菌性、延伸性、空孔
率、透気度、透湿度および耐水圧性を評価または測定し
た。結果を表1に示す。
(Example 3) Instead of LLDPE, polypropylene (manufactured by Mitsui Petrochemical Industry Co., Ltd., Hypol F-) was used.
600, MFR: 6 g / 10 minutes, density: 0.91 g / c
m 3 ), and the cylinder temperature is 160/200/23
An antibacterial porous film was produced in the same manner as in Example 1 except that 0 ° C., the die temperature was 230 ° C., and the film stretching temperature was 110 ° C., and the antibacterial property, the stretchability, the porosity, and the transparency were measured. The air quality, moisture permeability and water pressure resistance were evaluated or measured. The results are shown in Table 1.

【0039】(比較例1)LLDPE(三井石油化学工
業社製、ウルトゼックス2021L、MFR:2.1g
/10分、密度:0.920g/cm3 )のみを、二軸
押出機(日本製鋼社製、TEX−44、スクリュー径:
44mm)に供給してシリンダー温度:120/140
/190℃で溶融混練した後、ダイス温度:220℃の
Tダイから押出し、引取速度:6m/minで引き取っ
て、厚さ500μmのフィルムを得た。得られたフィル
ムについて、抗菌性、延伸性、空孔率、透気度、透湿度
および耐水圧性を、実施例1と同様にして、評価または
測定した。結果を表1に示す。
(Comparative Example 1) LLDPE (Mitsui Petrochemical Co., Ltd., Ultzex 2021L, MFR: 2.1 g)
/ 10 minutes, density: 0.920 g / cm 3 ) only, using a twin-screw extruder (manufactured by Nippon Steel Co., Ltd., TEX-44, screw diameter:
44 mm) and cylinder temperature: 120/140
After melt-kneading at / 190 ° C, it was extruded from a T-die at a die temperature of 220 ° C and taken at a take-up speed of 6 m / min to obtain a film having a thickness of 500 µm. The obtained film was evaluated or measured for antibacterial property, stretchability, porosity, air permeability, moisture permeability and water pressure resistance in the same manner as in Example 1. The results are shown in Table 1.

【0040】(比較例2)LLDPE(三井石油化学工
業社製、ウルトゼックス2021L、MFR:2.1g
/10分、密度:0.920g/cm3 )50重量部
と、炭酸カルシウム(竹原化学社製、WS#1500、
平均粒径:2.5μm)50重量部と、粉末状抗菌剤
((株)シナネンゼオミック製、ゼオミック)1重量部
とを、タンブラーで撹拌混合した。得られた混合物を、
二軸押出機(日本製鋼社製、TEX−44、スクリュー
径:44mm)に供給してシリンダー温度:120/1
40/190℃で溶融混練した後、ダイス温度:220
℃のTダイから押出し、引取速度:6m/minで引き
取って、厚さ500μmのフィルムを得た。得られたフ
ィルムについて、抗菌性、延伸性、空孔率、透気度、透
湿度および耐水圧性を、実施例1と同様にして、評価ま
たは測定した。結果を表1に示す。
(Comparative Example 2) LLDPE (Mitsui Petrochemical Co., Ltd., Ultzex 2021L, MFR: 2.1 g)
/ 10 minutes, density: 0.920 g / cm 3 ) 50 parts by weight, calcium carbonate (manufactured by Takehara Chemical Co., Ltd., WS # 1500,
50 parts by weight (average particle diameter: 2.5 μm) and 1 part by weight of a powdered antibacterial agent (Zeomic, manufactured by Sinanene Zeomic Co., Ltd.) were mixed by stirring with a tumbler. The resulting mixture is
Cylinder temperature: 120/1 by supplying to a twin-screw extruder (TEX-44, screw diameter: 44 mm, manufactured by Nippon Steel Co., Ltd.)
After melt-kneading at 40/190 ° C, die temperature: 220
The film was extruded from a T-die at a temperature of ℃ and drawn at a take-up speed of 6 m / min to obtain a film having a thickness of 500 μm. The obtained film was evaluated or measured for antibacterial property, stretchability, porosity, air permeability, moisture permeability and water pressure resistance in the same manner as in Example 1. The results are shown in Table 1.

【0041】(比較例3)粉末状抗菌剤((株)シナネ
ンゼオミック製、ゼオミック)の使用量を2重量部とし
た以外は、比較例2と同様にして、厚さ500μmのフ
ィルムを得た。得られたフィルムについて、抗菌性、延
伸性、空孔率、透気度、透湿度および耐水圧性を、実施
例1と同様にして、評価または測定した。結果を表1に
示す。
(Comparative Example 3) A film having a thickness of 500 µm was obtained in the same manner as in Comparative Example 2 except that the amount of the powdered antibacterial agent (Zenomic, manufactured by Sinane Zeomic Co., Ltd.) was changed to 2 parts by weight. . The obtained film was evaluated or measured for antibacterial property, stretchability, porosity, air permeability, moisture permeability and water pressure resistance in the same manner as in Example 1. The results are shown in Table 1.

【0042】(比較例4)粉末状抗菌剤を使用しない以
外は、実施例1と同様にして、延伸フィルムを製造し、
その抗菌性、延伸性、空孔率、透気度、透湿度および耐
水圧性を、実施例1と同様にして、評価または測定し
た。結果を表1に示す。
Comparative Example 4 A stretched film was produced in the same manner as in Example 1 except that the powdered antibacterial agent was not used.
The antibacterial property, stretchability, porosity, air permeability, moisture permeability and water pressure resistance were evaluated or measured in the same manner as in Example 1. The results are shown in Table 1.

【0043】(比較例5)延伸処理として、延伸倍率が
縦1.2倍の一軸延伸を行った以外は、実施例1と同様
にして延伸フィルムを製造し、その抗菌性、延伸性、空
孔率、透気度、透湿度および耐水圧性を、実施例1と同
様にして、評価または測定した。結果を表1に示す。
(Comparative Example 5) A stretched film was produced in the same manner as in Example 1 except that the stretching treatment was uniaxial stretching with a stretching ratio of 1.2 times in the longitudinal direction. Porosity, air permeability, moisture permeability and water pressure resistance were evaluated or measured in the same manner as in Example 1. The results are shown in Table 1.

【0044】[0044]

【表1】 [Table 1]

【0045】[0045]

【発明の効果】本発明の抗菌性多孔フィルムは、多孔性
を有し、抗菌剤と空気との接触面積が大きく、少量の抗
菌剤により優れた抗菌性を発揮することができる。
The antibacterial porous film of the present invention has porosity, has a large contact area between the antibacterial agent and air, and can exhibit excellent antibacterial properties with a small amount of the antibacterial agent.

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】ポリオレフィン樹脂と、抗菌剤と、充填剤
を含む樹脂組成物のフィルムまたはシートを延伸してな
る抗菌性多孔フィルム。
1. An antibacterial porous film obtained by stretching a film or sheet of a resin composition containing a polyolefin resin, an antibacterial agent and a filler.
【請求項2】空孔率が50%以上である請求項1に記載
の抗菌性多孔フィルム。
2. The antibacterial porous film according to claim 1, which has a porosity of 50% or more.
【請求項3】前記樹脂組成物が、ポリオレフィン樹脂1
00重量部、抗菌剤0.2〜5重量部、充填剤5〜20
0重量部を含むものである請求項1または2に記載の抗
菌性多孔フィルム。
3. The polyolefin resin 1 as the resin composition.
00 parts by weight, antibacterial agent 0.2-5 parts by weight, filler 5-20
The antibacterial porous film according to claim 1 or 2, which comprises 0 part by weight.
【請求項4】透気度が1000sec/100cc以下
のものである請求項1〜3のいずれかに記載の抗菌性多
孔フィルム。
4. The antibacterial porous film according to claim 1, which has an air permeability of 1000 sec / 100 cc or less.
【請求項5】耐水圧が1000mmH2 O以上のもので
ある請求項1〜4のいずれかに記載の抗菌性多孔フィル
ム。
5. The antibacterial porous film according to claim 1, which has a water pressure resistance of 1000 mmH 2 O or more.
【請求項6】ポリオレフィン樹脂と、抗菌剤と、充填剤
とを含む樹脂組成物を、フィルムまたはシートに溶融成
形した後、延伸する工程を有する抗菌性多孔フィルムの
製造方法。
6. A method for producing an antibacterial porous film, which comprises a step of melt-molding a resin composition containing a polyolefin resin, an antibacterial agent, and a filler into a film or sheet, and then stretching.
【請求項7】前記樹脂組成物が、ポリオレフィン樹脂1
00重量部、抗菌剤0.2〜5重量部、充填剤5〜20
0重量部を含むものである請求項6に記載の抗菌性多孔
フィルムの製造方法。
7. The polyolefin resin 1 is used as the resin composition.
00 parts by weight, antibacterial agent 0.2-5 parts by weight, filler 5-20
The method for producing an antibacterial porous film according to claim 6, which comprises 0 part by weight.
【請求項8】前記延伸処理が、一軸延伸処理である請求
項6または7に記載の抗菌性多孔フィルムの製造方法。
8. The method for producing an antibacterial porous film according to claim 6, wherein the stretching treatment is uniaxial stretching treatment.
【請求項9】前記延伸処理が、二軸延伸処理である請求
項6または7に記載の抗菌性多孔フィルムの製造方法。
9. The method for producing an antibacterial porous film according to claim 6, wherein the stretching treatment is biaxial stretching treatment.
JP20103195A 1995-08-07 1995-08-07 Antibacterial porous film and method for producing the same Pending JPH0948868A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20103195A JPH0948868A (en) 1995-08-07 1995-08-07 Antibacterial porous film and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20103195A JPH0948868A (en) 1995-08-07 1995-08-07 Antibacterial porous film and method for producing the same

Publications (1)

Publication Number Publication Date
JPH0948868A true JPH0948868A (en) 1997-02-18

Family

ID=16434304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20103195A Pending JPH0948868A (en) 1995-08-07 1995-08-07 Antibacterial porous film and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0948868A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005336363A (en) * 2004-05-27 2005-12-08 Kao Corp Antibacterial moisture permeable sheet
KR100755346B1 (en) * 2007-03-14 2007-09-04 최문호 Film Freshness Retainer
JP2010188426A (en) * 2009-01-26 2010-09-02 Emprie Technology Development LLC Cleaning sheet

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005336363A (en) * 2004-05-27 2005-12-08 Kao Corp Antibacterial moisture permeable sheet
KR100755346B1 (en) * 2007-03-14 2007-09-04 최문호 Film Freshness Retainer
JP2010188426A (en) * 2009-01-26 2010-09-02 Emprie Technology Development LLC Cleaning sheet

Similar Documents

Publication Publication Date Title
US5008296A (en) Breathable microporous film
JP3291307B2 (en) Oriented polymeric microporous film
JPH05230325A (en) Antibacterial, antifungal polyacetal resin composition
JPH0362738B2 (en)
JP2021167365A (en) Elastic film and its manufacturing method
JPH0948868A (en) Antibacterial porous film and method for producing the same
JPH11116715A (en) Porous film or sheet
JPS6179620A (en) Porous film
WO1995023186A1 (en) Polyolefin resin composition and resin film
JP2809674B2 (en) Stretched film with antibacterial action
JPH0858043A (en) Breathable composite film and manufacture thereof
JPH0649253A (en) Porous antimicrobial film and its production
JP3461951B2 (en) Polyolefin composition
JP2006241276A (en) Polyethylene porous film
JPH10219048A (en) Polypropylene composition
JP4484272B2 (en) Flexible resin magnet composition
JPH0723432B2 (en) Porous film
JPH07292260A (en) Drug-containing resin composition and resin molded product
JPH03181538A (en) Antifungal polyolefin composition
JPH0684449B2 (en) Breathable film
JPS61200142A (en) Water-absorption polyolefin resin composition
US20250277102A1 (en) Anti-fogging composition and anti-fogging plastics prepared therefrom
JP3540532B2 (en) Antibacterial flame-retardant resin composition
JPS5930833A (en) Preparation of porous sheet
JPH059344A (en) Antimicrobial composition and its molding

Legal Events

Date Code Title Description
A977 Report on retrieval

Effective date: 20040413

Free format text: JAPANESE INTERMEDIATE CODE: A971007

A131 Notification of reasons for refusal

Effective date: 20040420

Free format text: JAPANESE INTERMEDIATE CODE: A131

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040824